全球細胞增殖市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

細胞增殖市場預計將從 2025 年的 198.1 億美元成長到 2034 年的 565.4 億美元，2026 年至 2034 年的複合年成長率為 12.36%。

由於細胞療法和再生醫學的需求不斷成長，全球細胞增殖市場正經歷快速成長。細胞增殖是生物製藥開發、幹細胞研究和癌症治療的關鍵過程。對個人化醫療日益成長的關注進一步加速了先進細胞培養技術的應用。

關鍵促進因素包括生物技術投資的增加、慢性病盛行率的上升以及幹細胞研究的進展。生物製藥生產和臨床試驗的擴展也推動了對高效細胞增殖解決方案的需求。自動化細胞培養系統等技術創新正在提高擴充性和效率。

未來，隨著再生醫學和組織工程的持續發展，市場預計將顯著成長。政府對生命科學研究的支持和資助將進一步提振市場前景。隨著醫療產業向先進治療方法轉型，細胞增殖市場將發揮至關重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球細胞增生市場：依細胞類型分類

• 市場分析、洞察與預測
• 人類細胞
• 幹細胞
• 分化細胞
• 動物細胞

第5章 全球細胞增殖市場：依產品類型分類

• 市場分析、洞察與預測
• 裝置
• 消耗品
• 一次性產品

第6章 全球細胞增殖市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 首席行銷長和首席營收官
• 生物技術和製藥公司
• 學術研究機構

第7章 全球細胞增生市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • GE HealthCare Technologies
  • Danaher Corporation
  • Merck KGaA
  • Becton Dickinson
  • Lonza Group Ltd
  • Bio Techne Corporation
  • Corning Incorporated
  • Eppendorf AG
  • Miltenyi Biotec
  • CellGenix GmbH
  • STEMCELL Technologies Inc
  • HiMedia Laboratories Pvt. Ltd
  • CryoLogic Pty Ltd
  • Bio-Life Solutions Inc

The Cell Expansion Market size is expected to reach USD 56.54 Billion in 2034 from USD 19.81 Billion (2025) growing at a CAGR of 12.36% during 2026-2034.

The global cell expansion market is experiencing rapid growth due to increasing demand for cell-based therapies and regenerative medicine. Cell expansion is a critical process in the development of biologics, stem cell research, and cancer therapies. The growing focus on personalized medicine has further accelerated the adoption of advanced cell culture technologies.

Key drivers include rising investments in biotechnology, increasing prevalence of chronic diseases, and advancements in stem cell research. The expansion of biopharmaceutical manufacturing and clinical trials has also boosted demand for efficient cell expansion solutions. Technological innovations, such as automated cell culture systems, are improving scalability and efficiency.

In the future, the market is expected to grow significantly with the continued development of regenerative therapies and tissue engineering. Government support and funding for life sciences research will further enhance market prospects. As the healthcare industry shifts toward advanced treatment approaches, the cell expansion market will play a crucial role.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Cell Type

• Human Cells
• Stem Cells
• Differentiated Cells
• Animal Cells

By Product Type

• Instruments
• Consumables
• Disposables

By End User

• Hospitals
• CMOs & CROs
• Biotechnology & Pharmaceutical Companies
• Academic & Research Institutes

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, GE HealthCare Technologies, Danaher Corporation, Merck KGaA, Becton Dickinson, Lonza Group Ltd, Bio Techne Corporation, Corning Incorporated, Eppendorf AG, Miltenyi Biotec, CellGenix GmbH, STEMCELL Technologies Inc, HiMedia Laboratories Pvt Ltd, CryoLogic Pty Ltd, BioLife Solutions Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL EXPANSION MARKET: BY CELL TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Cell Type
• 4.2. Human Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Stem Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Differentiated Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Animal Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL EXPANSION MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product Type
• 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Disposables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL EXPANSION MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CMOs & CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CELL EXPANSION MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Cell Type
  • 7.2.2 By Product Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Cell Type
  • 7.3.2 By Product Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Cell Type
  • 7.4.2 By Product Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Cell Type
  • 7.5.2 By Product Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Cell Type
  • 7.6.2 By Product Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CELL EXPANSION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 GE HealthCare Technologies
  • 9.2.3 Danaher Corporation
  • 9.2.4 Merck KGaA
  • 9.2.5 Becton Dickinson
  • 9.2.6 Lonza Group Ltd
  • 9.2.7 Bio Techne Corporation
  • 9.2.8 Corning Incorporated
  • 9.2.9 Eppendorf AG
  • 9.2.10 Miltenyi Biotec
  • 9.2.11 CellGenix GmbH
  • 9.2.12 STEMCELL Technologies Inc
  • 9.2.13 HiMedia Laboratories Pvt. Ltd
  • 9.2.14 CryoLogic Pty Ltd
  • 9.2.15 Bio-Life Solutions Inc